President and CEO of the Institute for Optimizing Health Outcomes
Pro to the question "Should Prescription Drugs Be Advertised Directly to Consumers?"
"Drug or disease advertisements contribute to public health by increasing appropriate consultation for undiagnosed or untreated health conditions.
As prescription medications require approval of a learned intermediary, advertisements do not lead to patients getting inappropriate medications.
Patient surveys suggest that direct-to-consumer information about pharmaceutical products serves an unmet patient need.
Direct-to-consumer drug information that is balanced, screened, and monitored can promote the appropriate use of drugs."
"Should Canada Allow Direct-to-Consumer Advertising of Prescription Drugs? YES," Canadian Family Physician, www.ncbi.nlm.nih.gov, Feb. 2009
Experts Individuals with MDs, DOs, PhDs, MPHs, or equivalent advanced degrees in fields relevant to pharmaceutical drugs and public health. Also top-level government officials (such as foreign leaders, US presidents, Founding Fathers, Supreme Court Justices, members of legislative bodies, cabinet members, military leaders, etc.) with positions relevant to pharmaceutical drugs and public health.
Involvement and Affiliations:
Board Member, Drug Information Association (DIA), July 1, 2013-June 30, 2016
Chair, International Alliance of Patients' Organizations, 2011-present
President and CEO, Institute for Optimizing Health Outcomes, 2005-present
President, Canadian Organization for Rare Disorders, 2005-present
Chair, Consumer Advocare Network, 1999-present
President & CEO, Anemia Institute for Research & Education, 2000-2005
Professor, Psychology, University of Windsor, Ontario, Canada, 1984-1999
Co-Vice-Chair, Steering Committee of Health Technology Assessment International Interest Group on Patient /Citizen Involvement
President, Canadian Hemophilia Society
Member, Board of Directors, Canadian Blood Services
Member, Board of Directors, National Blood Safety Council
Project Coordinator, Policy Dialogues for the Commission on the Future of Healthcare in Canada
Consultant, Ontario Premier’s Advisory Board on Organ Donation
Member, Health Canada’s Expert Advisory Committee on Vigilance of Health Products and Expert Advisory Panel on Special Access Programme
PhD, Social Psychology, McGill University (Montreal, Canada), 1981